SOL Capital Management CO Reduces Stock Holdings in Humana Inc. $HUM

SOL Capital Management CO reduced its holdings in Humana Inc. (NYSE:HUM) by 13.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,744 shares of the insurance provider’s stock after selling 2,024 shares during the quarter. SOL Capital Management CO’s holdings in Humana were worth $3,316,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Evergreen Capital Management LLC acquired a new stake in Humana during the third quarter worth about $244,000. First National Advisers LLC increased its position in Humana by 3.8% during the 3rd quarter. First National Advisers LLC now owns 2,809 shares of the insurance provider’s stock worth $731,000 after purchasing an additional 104 shares in the last quarter. Belfer Management LLC purchased a new position in Humana in the third quarter valued at approximately $202,000. Campbell & CO Investment Adviser LLC acquired a new position in Humana during the third quarter valued at approximately $700,000. Finally, Fjarde AP Fonden Fourth Swedish National Pension Fund grew its stake in Humana by 2.5% during the third quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund now owns 26,336 shares of the insurance provider’s stock worth $6,852,000 after buying an additional 648 shares during the period. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Trading Down 3.8%

Shares of NYSE HUM opened at $273.02 on Friday. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 0.68. The company has a market cap of $32.84 billion, a price-to-earnings ratio of 25.59, a price-to-earnings-growth ratio of 2.34 and a beta of 0.45. The stock’s 50 day simple moving average is $255.33 and its 200 day simple moving average is $263.55.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.95 by $0.29. The company had revenue of $32.65 billion during the quarter, compared to analyst estimates of $31.99 billion. Humana had a return on equity of 12.86% and a net margin of 1.02%.The firm’s quarterly revenue was up 11.1% on a year-over-year basis. During the same quarter in the previous year, the firm posted $4.16 EPS. Equities research analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.3%. Humana’s payout ratio is 33.18%.

Analysts Set New Price Targets

HUM has been the topic of several research reports. Morgan Stanley reissued an “underperform” rating on shares of Humana in a research report on Thursday, December 18th. KeyCorp reiterated a “sector weight” rating on shares of Humana in a report on Friday, December 12th. Guggenheim restated a “buy” rating on shares of Humana in a report on Friday, October 3rd. Evercore ISI assumed coverage on shares of Humana in a research report on Monday, September 22nd. They set an “in-line” rating and a $295.00 target price on the stock. Finally, Zacks Research lowered shares of Humana from a “hold” rating to a “strong sell” rating in a report on Thursday, January 1st. Eight equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $293.37.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.